Edgewise Therapeutics, Inc. (EWTX)
45.46
+1.83
(+4.19%)
USD |
NASDAQ |
Sep 16, 16:00
45.99
+0.53
(+1.17%)
After-Hours: 20:00
Edgewise Therapeutics Price to Book Value : 10.93 for Sept. 16, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 15, 2026 | 10.49 |
| September 14, 2026 | 10.73 |
| September 11, 2026 | 10.68 |
| September 10, 2026 | 10.32 |
| September 09, 2026 | 10.44 |
| September 08, 2026 | 10.54 |
| September 04, 2026 | 10.36 |
| September 03, 2026 | 10.09 |
| September 02, 2026 | 10.10 |
| September 01, 2026 | 10.16 |
| August 31, 2026 | 10.05 |
| August 28, 2026 | 10.29 |
| August 27, 2026 | 10.63 |
| August 26, 2026 | 10.67 |
| August 25, 2026 | 10.63 |
| August 24, 2026 | 10.76 |
| August 21, 2026 | 10.63 |
| August 20, 2026 | 10.41 |
| August 19, 2026 | 11.17 |
| August 18, 2026 | 10.61 |
| August 17, 2026 | 10.59 |
| August 14, 2026 | 10.62 |
| August 13, 2026 | 10.39 |
| August 12, 2026 | 10.48 |
| August 11, 2026 | 10.66 |
| Date | Value |
|---|---|
| August 10, 2026 | 10.72 |
| August 07, 2026 | 10.47 |
| August 06, 2026 | 10.68 |
| August 05, 2026 | 10.82 |
| August 04, 2026 | 10.75 |
| August 03, 2026 | 9.232 |
| July 31, 2026 | 9.244 |
| July 30, 2026 | 9.891 |
| July 29, 2026 | 9.561 |
| July 28, 2026 | 9.705 |
| July 27, 2026 | 10.01 |
| July 24, 2026 | 9.823 |
| July 23, 2026 | 9.450 |
| July 22, 2026 | 9.220 |
| July 21, 2026 | 9.520 |
| July 20, 2026 | 9.335 |
| July 17, 2026 | 9.564 |
| July 16, 2026 | 9.186 |
| July 15, 2026 | 9.821 |
| July 14, 2026 | 9.556 |
| July 13, 2026 | 9.927 |
| July 10, 2026 | 10.92 |
| July 09, 2026 | 11.63 |
| July 08, 2026 | 11.14 |
| July 07, 2026 | 10.37 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Cocrystal Pharma, Inc. | 15.26 |
| CNBX Pharmaceuticals, Inc. | -- |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 0.9478 |
| Fulcrum Therapeutics, Inc. | 0.9293 |
Price to Book Value Related Metrics
| PEG Ratio | -1.303 |
| Price | 45.46 |
| Earnings Yield | -4.07% |
| Market Cap | 4.900B |
| PEGY Ratio | -1.303 |